title: Liquid crystalline Pluronic 105 pharmacogels as drug delivery systems: preparation, characterization, and in vitro transdermal release.
abstract: In this study, we report the results of our investigations on the percutaneous permeation profiles of Diclofenac sodium, Paracetamol, Propanolol hydrochloride, and alpha-Tocopherol from the different lyotropic liquid crystalline phases obtained by Pluronic P105/water mixtures, in order to understand if the particular assembly shown in the formulations could influence the delivery across the skin. Recent studies have focused on the Pluronic liquid crystalline phases to evaluate the potential use of these phases in drug delivery, but no comparative investigation has been yet performed on the drug permeation from the different liquid crystalline phases obtained by the same Pluronic surfactant. The cubic, hexagonal, and lamellar mesophases (loading the above-mentioned drug) were characterized by Deuterium Nuclear Magnetic Resonance spectroscopy and Polarized Optical Microscopy observations. Results revealed that the liquid crystalline gel microscopic structure obtained in the different formulations drastically affects the drug percutaneous availability. As a consequence these systems could be proposed as novel transdermal drug delivery systems.
authors.affiliation: Department of Pharmaceutical Sciences, University of Calabria, Ed. Polifunzionale, Rende, Italy. rita.muzzalupo@unical.it
authors.forename: Rita
authors.initials: R
authors.lastname: Muzzalupo
authors.forename: Lorena
authors.initials: L
authors.lastname: Tavano
authors.forename: Fiore Pasquale
authors.initials: FP
authors.lastname: Nicoletta
authors.forename: Sonia
authors.initials: S
authors.lastname: Trombino
authors.forename: Roberta
authors.initials: R
authors.lastname: Cassano
authors.forename: Nevio
authors.initials: N
authors.lastname: Picci
mesh_terms: D000279:Administration, Cutaneous; D016503:Drug Delivery Systems; D009682:Magnetic Resonance Spectroscopy; D020442:Poloxamer
chemical_list: D020442:Poloxamer